Herbalife CFO John DeSimone pushed back against Bill Ackman on Tuesday, telling CNBC in an interview that "his bark is always worse than his bite."» Read More
The announcement that GSK is planning to spend $350 million plus to get a slice of a U.K. biotech's cancer drugs has raised eyebrows.
As the ASCO meeting gets underway in Chicago, here's a look at where we stand in the fight against cancer.
Fifty-one percent of voters are tired of hearing congressional candidates talk about Obamacare, and want to hear about things like jobs.
A report found the government doled out at least $19 billion in subsidies over 18 years to companies producing key ingredients in junk food.
Health care advocates said on Thursday that four insurers offering plans in the new federal marketplace discriminated against people with H.I.V.
A key theme at this year's ASCO meeting will be immunotherapies. How do these treatments work?
The three physicians ordered so many individual tests that their patients averaged one every other day.
The next place cybercriminals will steal your information is from your doctor’s computer
Men with ED may be able to avoid the awkwardness of a doctor's visit by buying Cialis without a prescription, under a new proposal. NYT reports.
Prescription drugs costs will continue playing a key role in medical-related debt and bankruptcies despite the expansion of insurance.
The problem: prescription drug costs stretch many peoples' budgets and some are forced into bankruptcy. Here are tips to avoid that.
GSK has invited private equity firms to consider making offers for a range of its older drugs, three people with direct knowledge of the matter said.
E-cigarette sales at US convenience stores fell for the first time, underlining a shift to larger, cheaper devices, the FT reports.
More than 7 out of 10 Americans says Obamacare has had a mostly negative effect or not much of one at all on the US, according to a Bankrate survey.
Sixty-three percent of Australians are overweight, a study published Thursday showed, highlighting the country's growing obesity problem.
GlaxoSmithKline salespeople in China say the company won't reimburse them for bribes they were ordered to pay out of pocket. FT reports.
Canadian drugmaker Valeant Pharmaceuticals International raised the cash component of its offer for Botox-maker Allergan by $10 per share.
More employees are getting hit with higher health premiums and co-payments, and many can't cover unexpected medical expenses. USA Today reports.
Swiss food group Nestle stepped up its drive into the fast-growing skincare market on Wednesday.
Shares of WellCare Health Plans and Centene surged Tuesday on speculation that one of the two Medicaid insurance providers could be acquired.
Get the best of CNBC in your inbox